Physician profile
April E Harris
NPI 1316940422
$3,972.55
in general payments reported to CMS, 2019-2025
18 companies · $507 in 2025
The $507 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $211 · 2021: $192 · 2022: $1,036 · 2023: $803 · 2024: $1,088 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,397.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $1,426.42 | 2019-2024 | Iluvien, Yutiq |
| Regeneron Healthcare Solutions, INC. | $991.57 | 2019-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $432.17 | 2021-2025 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $275.51 | 2023-2025 | Syfovre |
| Astellas Pharma US INC | $258.54 | 2023-2025 | Izervay |
| Novartis Pharmaceuticals Corporation | $211.98 | 2019-2020 | |
| Abbvie INC. | $79.49 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $65.62 | 2022 | |
| Alcon Vision LLC | $42.12 | 2023 | Constellation |
| Ani Pharmaceuticals, INC. | $37.74 | 2025 | Yutiq, Iluvien |
| Genentech, INC. | $26.30 | 2024 | Vabysmo, Susvimo |
| Spark Therapeutics, INC. | $24.29 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Coherus Oncology, INC. | $17.42 | 2023 | |
| Kala Pharmaceuticals, INC. | $17.25 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $17.22 | 2020 | |
| Biogen, INC. | $15.65 | 2022 | |
| Allergan, INC. | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.